HA ng·mL−1 | p-value | HYAL-1 ng·mL−1 | p-value | |
Inhaled corticosteroids | ||||
Yes | 21.7 (10.1–38.8) | 0.437 | 1.7 (1.2–2.4) | 0.632 |
No | 22.6 (13.1–44.5) | 1.6 (1.1–2.43) | ||
Systemic corticosteroids | ||||
Yes | 20.0 (9.0–46.9) | 0.846 | 1.7 (1.4–2.6) | 0.637 |
No | 22.3 (10.3–38.8) | 1.7 (1.2–2.4) | ||
Long-acting β2-agonists+corticosteroids | ||||
Yes | 21.2 (9.4–38.1) | 0.093 | 1.7 (1.2–2.5) | 0.640 |
No | 23.3 (13.6–44.2) | 1.7 (1.1–2.4) | ||
Long-acting muscarinic antagonists | ||||
Yes | 21.2 (9.7–38.0) | 0.324 | 1.7 (1.2–2.4) | 0.936 |
No | 25.2 (12.1–41.2) | 1.7 (1.1–2.5) |
Data are presented as median (interquartile range), unless otherwise stated.